Stanford Expert Proposes Fix for Generic Drug Shortages

Nine out of ten prescriptions filled in America are generic drugs, but keeping them consistently available has been a struggle that affects millions of patients.

More than 60% of generic drug shortages stem from quality concerns, according to the FDA. Many manufacturers, particularly those based overseas, have faced recalls and import bans after violating safety protocols.

Kevin Schulman, deputy director of Stanford University's Clinical Excellence Research Center, believes he has found a practical answer. His solution centers on something straightforward: letting independent, accredited laboratories test generic drugs before they reach pharmacy shelves.

The approach builds on real-world experience. Schulman has worked with Valisure, an independent lab that discovered impurities in widely used medications that might have otherwise gone undetected.

His proposal calls for the FDA to encourage testing by these outside labs, creating an extra layer of quality assurance. This would catch problems before drugs are distributed to patients, preventing both shortages and potential health risks.

The Bright Side

This idea represents a shift from simply reacting to quality problems after they happen to preventing them in the first place. Independent testing could give doctors and patients confidence that their generic medications meet the same standards as brand-name drugs.

The timing matters because generic drugs make healthcare affordable for millions of Americans. When shortages hit, patients face impossible choices between paying more for brand-name alternatives or going without needed medications entirely.

Independent labs could also speed up the process of identifying which manufacturers consistently produce quality products. Over time, this information would help healthcare providers and pharmacies make better purchasing decisions.

The proposal doesn't require reinventing the wheel or massive government spending. Accredited independent labs already exist and have proven they can identify quality issues that slip through current oversight.

For patients who've watched their pharmacies struggle to fill prescriptions or experienced the anxiety of medication switches during shortages, this solution offers something invaluable: reliability in the medications that keep them healthy.